Royal Bank Of Canada Mersana Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 11,455 shares of MRSN stock, worth $6,758. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,455

Previous 10,670 7.36%

Holding current value

$6,758

Previous $21,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.23 - $2.25 $965 - $1,766	785 Added 7.36%	11,455 $21,000
Q2 2024 Aug 14, 2024	BUY	$2.0 - $4.45 $16,244 - $36,142	8,122 Added 318.76%	10,670 $21,000
Q1 2024 Nov 05, 2024	SELL	$2.16 - $5.94 $17,543 - $48,244	-8,122 Reduced 76.12%	2,548 $11,000
Q1 2024 May 15, 2024	SELL	$2.16 - $5.94 $69,800 - $191,951	-32,315 Reduced 92.69%	2,548 $11,000
Q4 2023 Feb 14, 2024	BUY	$1.11 - $2.34 $22,125 - $46,643	19,933 Added 133.51%	34,863 $80,000
Q3 2023 Nov 14, 2023	BUY	$1.06 - $3.91 $2,171 - $8,011	2,049 Added 15.91%	14,930 $18,000
Q2 2023 Aug 14, 2023	BUY	$3.08 - $9.55 $23,583 - $73,124	7,657 Added 146.57%	12,881 $42,000
Q1 2023 May 15, 2023	SELL	$4.0 - $7.02 $31,764 - $55,745	-7,941 Reduced 60.32%	5,224 $21,000
Q4 2022 Feb 14, 2023	BUY	$5.65 - $7.86 $58,624 - $81,555	10,376 Added 372.03%	13,165 $77,000
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $10,625 - $18,360	2,295 Added 464.57%	2,789 $18,000
Q2 2022 Aug 15, 2022	SELL	$2.84 - $5.0 $11,084 - $19,515	-3,903 Reduced 88.77%	494 $2,000
Q1 2022 May 16, 2022	SELL	$3.74 - $6.63 $40,021 - $70,947	-10,701 Reduced 70.88%	4,397 $18,000
Q4 2021 Feb 14, 2022	BUY	$5.48 - $9.86 $44,700 - $80,428	8,157 Added 117.52%	15,098 $94,000
Q3 2021 Nov 15, 2021	BUY	$8.56 - $14.47 $19,054 - $32,210	2,226 Added 47.21%	6,941 $66,000
Q2 2021 Aug 16, 2021	BUY	$13.28 - $18.07 $62,615 - $85,200	4,715 New	4,715 $64,000

Others Institutions Holding MRSN

# of Institutions

126

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $57.3M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Mersana Therapeutics, Inc. Transaction History